 - The subject has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 30 days, 5 half-lives or twice the duration of the biological effect of the investigational product whichever is longer. Subjects who previously received GSK2881078 are allowed to participate in this trial, with the same timeline restrictions. 